Globon Co. Ltd (KQ:019660) — Market Cap & Net Worth
Market Cap & Net Worth: Globon Co. Ltd (019660)
Globon Co. Ltd (KQ:019660) has a market capitalization of $32.70 Million (₩48.25 Billion) as of August 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #23400 globally and #1549 in its home market, demonstrating a -9.54% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Globon Co. Ltd's stock price ₩1659.00 by its total outstanding shares 29083100 (29.08 Million). See reinvestment intensity of Globon Co. Ltd to understand how much of operating cash flow is reinvested back into capital assets.
Globon Co. Ltd Market Cap History: 2015 to 2026
Globon Co. Ltd's market capitalization history from 2015 to 2026. Data shows change from $114.31 Million to $32.70 Million (-5.74% CAGR).
Index Memberships
Globon Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$202.56 Billion | 0.02% | #764 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$202.56 Billion | 0.02% | #764 of 1384 |
Weight: Globon Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Globon Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Globon Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Globon Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $57.16 Million | $14.47 Billion | -$6.20 Billion | 0.00x | N/A |
| 2018 | $75.49 Million | $7.11 Billion | -$8.63 Billion | 0.01x | N/A |
| 2019 | $61.99 Million | $29.81 Billion | $1.73 Billion | 0.00x | 0.04x |
| 2020 | $66.22 Million | $10.31 Billion | -$9.33 Billion | 0.01x | N/A |
| 2021 | $58.14 Million | $4.22 Billion | -$5.10 Billion | 0.01x | N/A |
| 2022 | $35.18 Million | $5.18 Billion | -$11.64 Billion | 0.01x | N/A |
| 2023 | $19.73 Million | $18.48 Billion | -$6.40 Billion | 0.00x | N/A |
| 2024 | $11.65 Million | $20.31 Billion | -$4.49 Billion | 0.00x | N/A |
| 2025 | $51.34 Million | $17.33 Billion | $553.17 Million | 0.00x | 0.09x |
| 2026 | $32.70 Million | $12.95 Billion | -$5.76 Billion | 0.00x | N/A |
Competitor Companies of 019660 by Market Capitalization
Companies near Globon Co. Ltd in the global market cap rankings as of August 4, 2026.
Key companies related to Globon Co. Ltd by market ranking:
- NeoPharm CO. LTD (KQ:092730): Ranked #19006 globally with a market cap of $103.51 Million USD ( ₩152.74 Billion KRW).
- HYUNDAI BIOLAND Co.Ltd (KQ:052260): Ranked #23383 globally with a market cap of $32.83 Million USD ( ₩48.45 Billion KRW).
- Gentrogroup Co. Ltd. (KQ:083660): Ranked #29409 globally with a market cap of $3.08 Million USD ( ₩4.54 Billion KRW).
- P3 Health Partners Inc (NASDAQ:PIII): Ranked #23401 globally with a market cap of $32.69 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #19006 | NeoPharm CO. LTD | KQ:092730 | $103.51 Million | ₩19120.00 |
| #23383 | HYUNDAI BIOLAND Co.Ltd | KQ:052260 | $32.83 Million | ₩3230.00 |
| #29409 | Gentrogroup Co. Ltd. | KQ:083660 | $3.08 Million | ₩230.00 |
| #23401 | P3 Health Partners Inc | NASDAQ:PIII | $32.69 Million | $9.83 |
Globon Co. Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Globon Co. Ltd's market cap moved from $114.31 Million to $ 32.70 Million, with a yearly change of -5.74%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩32.70 Million | -36.31% |
| 2025 | ₩51.34 Million | +340.78% |
| 2024 | ₩11.65 Million | -40.96% |
| 2023 | ₩19.73 Million | -43.92% |
| 2022 | ₩35.18 Million | -39.49% |
| 2021 | ₩58.14 Million | -12.20% |
| 2020 | ₩66.22 Million | +6.84% |
| 2019 | ₩61.99 Million | -17.89% |
| 2018 | ₩75.49 Million | +32.07% |
| 2017 | ₩57.16 Million | -35.70% |
| 2016 | ₩88.89 Million | -22.24% |
| 2015 | ₩114.31 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Globon Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $32.70 Million USD |
| MoneyControl | $32.70 Million USD |
| MarketWatch | $32.70 Million USD |
| marketcap.company | $32.70 Million USD |
| Reuters | $32.70 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Globon Co. Ltd
Globon Co., Ltd. engages in wholesale and retail of cosmetics. It is also involved in manufacturing of cosmetic containers and products; and selling household goods to retail customers. In addition, the company engages in the gasification combined cycle power plant and investment businesses. The company was formerly known as Veritas Investment Co., Ltd. and changed its name to Globon Co., Ltd. in… Read more